Bailing Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Crystal Structure

Cognitive Impairment

Dna Damage Response

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Zihan Cheng, Nianying Shang, Xiaoyu Wang, Yuying Kang, Jie Zhou, Jiaqi Lan, Jinping Hu, Ying Peng, Bailing Xu
Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide O -GlcNAcase Inhibitors for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry 67 (16) (2024)
Zihan Cheng, Nianying Shang, Xiaoyu Wang, Yuying Kang, Jie Zhou, Jiaqi Lan, Jinping Hu, Ying Peng, Bailing Xu
Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide O -GlcNAcase Inhibitors for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry (2024)
Zihan Cheng, Nianying Shang, Xiaoyu Wang, Yuying Kang, Jie Zhou, Jiaqi Lan, Jinping Hu, Ying Peng, Bailing Xu
Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide O -GlcNAcase Inhibitors for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry 67 (16) (2024)
Jie Zhou, Weiping Wang, Dong Liu, Shaofeng Xu, Xue Wang, Xinyuan Zhang, Xiaoyu Wang, Yan Li, Li Sheng, Xiao-Liang Wang, Bailing Xu
Discovery of 2-Ethoxy-5-isobutyramido- N -1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects. Journal of medicinal chemistry 67 (1) (2023)
Jie Zhou, Weiping Wang, Dong Liu, Shaofeng Xu, Xue Wang, Xinyuan Zhang, Xiaoyu Wang, Yan Li, Li Sheng, Xiao-Liang Wang, Bailing Xu
Discovery of 2-Ethoxy-5-isobutyramido- N -1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects. Journal of medicinal chemistry 67 (1) (2023)
Jie Zhou, Weiping Wang, Dong Liu, Shaofeng Xu, Xue Wang, Xinyuan Zhang, Xiaoyu Wang, Yan Li, Li Sheng, Xiao-Liang Wang, Bailing Xu
Discovery of 2-Ethoxy-5-isobutyramido- N -1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects. Journal of medicinal chemistry (2023)
Jie Zhou, Weiping Wang, Dong Liu, Shaofeng Xu, Xue Wang, Xinyuan Zhang, Xiaoyu Wang, Yan Li, Li Sheng, Xiao-Liang Wang, Bailing Xu
Discovery of 2-Ethoxy-5-isobutyramido- N -1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects. Journal of medicinal chemistry 67 (1) (2023)
Haoming Zhang, Xiaoyu Wang, Yanjun Wan, Liheng Liu, Jie Zhou, Pingping Li, Bailing Xu
Discovery of N -Arylsulfonyl-Indole-2-Carboxamide Derivatives as Galectin-3 and Galectin-8 C-Terminal Domain Inhibitors. ACS medicinal chemistry letters 14 (9) (2023)
Jie Zhou, Tingting Du, Xiaoyu Wang, Haiping Yao, Jialing Deng, Yan Li, Xiaoguang Chen, Li Sheng, Ming Ji, Bailing Xu
Discovery of Quinazoline-2,4(1 H ,3 H )-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis. Journal of medicinal chemistry (2023)
Xiaoyu Wang, Rui Zhao, Wenming Ji, Jie Zhou, Quan Liu, Linxiang Zhao, Zhufang Shen, Shuainan Liu, Bailing Xu
Discovery of Novel Indole Derivatives as Fructose-1,6-bisphosphatase Inhibitors and X-ray Cocrystal Structures Analysis. ACS medicinal chemistry letters 13 (1) (2021)
Jie Zhou, Ming Ji, Xiaoyu Wang, Hailong Zhao, Ran Cao, Jing Jin, Yan Li, Xianhong Chen, Li Sheng, Xiaoguang Chen, Bailing Xu
Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing 3-Substituted Piperizines as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis. Journal of medicinal chemistry 64 (22) (2021)
Jie Zhou, Jianbo Bie, Xiaoyu Wang, Quan Liu, Rongcui Li, Hualong Chen, Jinping Hu, Hui Cao, Wenming Ji, Yan Li, Shuainan Liu, Zhufang Shen, Bailing Xu
Discovery of N-Arylsulfonyl-Indole-2-Carboxamide Derivatives as Potent, Selective, and Orally Bioavailable Fructose-1,6-Bisphosphatase Inhibitors-Design, Synthesis, In Vivo Glucose Lowering Effects, and X-ray Crystal Complex Analysis. Journal of medicinal chemistry 63 (18) (2020)